Literature DB >> 3025733

Neurochemical substrates for opiate reinforcement.

G F Koob, F J Vaccarino, M Amalric, F E Bloom.   

Abstract

The studies reported herein summarize our work to date aimed at determining the neurochemical substrates for the reinforcing properties of opiates. Rats were trained to self-administer heroin intravenously in daily 3-hour sessions, and pharmacological blockade and neurotoxin-induced lesions were used to define the neurochemical substrates for this reinforcing action. Low-dose DA receptor blockade failed to alter heroin self-administration but significantly increased cocaine self-administration, presumably reflecting a decrease in the reinforcing effectiveness of cocaine. Destruction of presynaptic DA terminals within the N.Acc. produced extinction of cocaine, but not heroin, self-administration. Opiate receptor blockade with systemic naloxone increased heroin, but not cocaine, self-administration. Methylnaloxonium injections into the N.Acc. were effective in increasing heroin self-administration at doses one-eighth those observed for intracerebroventricular injections. Reinforcement has been explored using a place-preference procedure and a self-administration drug-substitution paradigm. Mu/delta agonists such as B-END readily produce a naloxone-reversible place preference. Fentanyl derivatives also produce place preference and substitute for heroin during self-administration. The kappa agonist U50-488 produces place aversion, not place preference, and does not readily substitute for heroin. Altogether, these results suggest that mu/delta receptor subtypes in the region of the N.Acc. may be an important neurochemical substrate for opiate reinforcement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025733

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  8 in total

1.  Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction.

Authors:  P V Piazza; V Deroche-Gamonent; F Rouge-Pont; M Le Moal
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

2.  Effects of compounding drug-related stimuli: escalation of heroin self-administration.

Authors:  L V Panlilio; S J Weiss; C W Schindler
Journal:  J Exp Anal Behav       Date:  2000-03       Impact factor: 2.468

Review 3.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

4.  Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use.

Authors:  Diana H Fishbein; Evgeny Krupitsky; Barbara A Flannery; Doris J Langevin; Georgiy Bobashev; Elena Verbitskaya; Cynthia B Augustine; Karen I Bolla; Edwin Zvartau; Barry Schech; Valentina Egorova; Natali Bushara; Marina Tsoy
Journal:  Drug Alcohol Depend       Date:  2007-03-26       Impact factor: 4.492

5.  The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

Authors:  Jane V Aldrich; Sanjeewa N Senadheera; Nicolette C Ross; Michelle L Ganno; Shainnel O Eans; Jay P McLaughlin
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

6.  The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

Authors:  Shainnel O Eans; Michelle L Ganno; Kate J Reilley; Kshitij A Patkar; Sanjeewa N Senadheera; Jane V Aldrich; Jay P McLaughlin
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys.

Authors:  S Stevens Negus; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

8.  The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens.

Authors:  Helene L Philogene-Khalid; Mary F Morrison; Nune Darbinian; Michael E Selzer; Joseph Schroeder; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.